Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. - Wikidata - wikimedia - TriplyDB

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.

http://www.wikidata.org/entity/Q34596441

about

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors Cancer concepts and principles: primer for the interventional oncologist-part II Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies Yttrium-90 microspheres: a review of its emerging clinical indications Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Outcomes following resection of intrahepatic cholangiocarcinoma Intrahepatic cholangiocarcinoma: expert consensus statement.Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience.Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.Targeted radionuclide therapy.Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.Intrahepatic cholangiocarcinoma: current perspectives.Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects.State of the art: radiolabeled microspheres treatment for liver malignancies.Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management.Multidisciplinary approaches to intrahepatic cholangiocarcinoma.An update on liver surgery for cholangiocarcinoma.Intraarterial therapies for primary liver cancer: state of the art.Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors.Evidence-based integration of selective internal radiation therapy into the management of cholangiocarcinoma.Transarterial approaches to primary and secondary hepatic malignancies.Multimodality treatment of intrahepatic cholangiocarcinoma: A review.Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Locoregional Therapies of Cholangiocarcinoma.Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study.Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE.Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case.

P2860

Q26741882-135C2CCE-563D-4FCE-8B76-B1F6C5ECE258 Q26781036-C0D7F8FB-7B4B-4AE1-A2CE-4934BBBC776E Q26796522-AFB9126F-03E8-4067-9D47-BBB3BEC46B0A Q26799046-94CC1A26-A6B9-4CA1-9543-4A0612AC1A15 Q27010961-967F6C8E-17DC-4DCA-8627-1A3FD6DA9947 Q28071594-70E4995C-1722-4A82-AB5E-DECB0B90009E Q28083856-7C983473-4DE9-4671-8932-EF52545A8B8B Q33621522-57300092-B87A-4C43-BB07-28A4A8D4B3D1 Q33844564-5C190BE9-BFDB-405D-A8AE-A59F8A0C0EA8 Q34650742-BCEE9E47-4E9F-45C1-BA64-28B98943B837 Q35202216-9A107CB2-D0BC-4B35-B45B-EE08BFA92624 Q35924971-F9859CA5-803D-4A6F-8108-380DDF4C5601 Q36080625-E5B67BA2-653F-465C-BEC8-1B9CD612905C Q36609503-10BFC0D4-B140-44C2-8B45-A078A9EBF1B2 Q37148148-736B5A99-5255-4B68-A2EE-B59129A5EEE2 Q37151082-11128808-D15F-4290-A68D-9F3E8B2B64A7 Q37347327-B6C42F17-74AC-4564-931B-E942EEC93853 Q37525291-DEC9BCA9-F68E-4130-8B42-ED5AC1B78C58 Q37601096-76C5139E-5EF4-4D45-A002-D5C2CB8A246D Q37669928-F4771C15-6396-4C64-99AC-D64A88F6541D Q37675072-36C4B25F-BC57-4EC6-BF86-133D039A972B Q37693928-26A11CCA-C83D-40FD-BCD8-F0D2056EBC51 Q38001351-2BA4B286-27CA-499D-B752-A1C4090CE331 Q38130469-15E31986-946E-4B6F-8422-4A2F263899DE Q38148476-2C17809B-8EC6-41A4-B37F-D12119C04D6C Q38149993-281A411E-4CA5-449C-9900-AF3593C6F744 Q38179344-0D9782A1-1BF0-4DDD-8096-D0CC90831396 Q38241076-40BF964F-B485-4F60-B1E7-48C1BC3F0303 Q38283685-8332DE6E-78EE-4EED-BE73-C06895625107 Q38488732-282710FC-D7E5-4B03-84B8-5C658BFE8B7D Q38707365-DC26569D-E1EF-465F-A548-069758E7B3E3 Q38739690-AC9B382D-254A-493C-A335-157DD63836A0 Q38778958-F798DF2A-A04F-452E-9F93-BD51B5F8C247 Q38812588-2922EF6C-4FA2-4D59-8F07-9DBE591F7A31 Q38947234-DCBD9E8A-5836-4A7E-94E0-E92DA1ECD92C Q38972508-A15D7A37-6563-4EC3-8EBD-D77DA169CB97 Q39048862-5D163A03-B771-4F2A-AC70-69CB3176BF79 Q39349626-D5BC9F77-1E00-471F-80BB-84B5089404DF Q41951208-AC358E63-68BE-4B46-B85E-2518835BAE63 Q42015945-1D8EAB0A-4B09-45C1-A811-A2A1CB63617A

P2860

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.

http://www.wikidata.org/entity/Q34596441

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Treatment of unresectable chol ...... s: results from a pilot study.

@ast

Treatment of unresectable chol ...... s: results from a pilot study.

@en

Treatment of unresectable chol ...... s: results from a pilot study.

@nl

type

label

Treatment of unresectable chol ...... s: results from a pilot study.

@ast

Treatment of unresectable chol ...... s: results from a pilot study.

@en

Treatment of unresectable chol ...... s: results from a pilot study.

@nl

prefLabel

Treatment of unresectable chol ...... s: results from a pilot study.

@ast

Treatment of unresectable chol ...... s: results from a pilot study.

@en

Treatment of unresectable chol ...... s: results from a pilot study.

@nl

P1433

Q34596441-228559F1-AE95-454A-86CB-A4E391862CF2

P1476

Q34596441-2574B16F-B5B1-4A08-8B6B-D3B1714A2FFB

P2093

Q34596441-22FDFFB9-4080-4AF5-81A3-87E7B695D484

Q34596441-2FA5C164-92B7-46EC-BE12-77EA79750F6F

Q34596441-38FFD2BA-A69E-4B23-8C37-2E9B3ADA8663

Q34596441-535415F3-5E3E-4A39-81FA-1A6F1801972D

Q34596441-54A39368-2948-4B8C-8156-DE489448A96B

Q34596441-6AF19E3E-EEF0-4690-8F7F-88EF89C6C0E4

Q34596441-8FCA09D1-0460-423A-B39F-F156586F9EDF

Q34596441-C0DEF2ED-C42C-42DA-BD45-CBE72CD40755

Q34596441-D3B0D18C-1EDC-4082-BB2C-AA25CA5EC1E4

Q34596441-F73CF472-17C7-4008-9341-14464FC680BB

P304

Q34596441-9D0CED5E-AACD-439D-B4B5-1E3E1DF86AFC

P31

Q34596441-20F9226A-8EED-488A-817F-D6A08E113823

P356

Q34596441-F15C5694-1143-467F-BB98-EF52A4CAB4EA

P407

Q34596441-BA0D8BF6-8C9E-4042-8A60-94B3A8441AFD

P433

Q34596441-855199EB-B87E-41E7-95D5-EB83EC8380ED

P478

Q34596441-F51640D2-BD57-4FCF-B0D1-4C76206F1B5C

P577

Q34596441-E7CDAB52-682E-4F22-BB75-333F80C6068B

P5875

Q34596441-75D8D190-5DDF-4B1A-8F49-012357760242

P698

Q34596441-12DCCE46-B478-4FC5-BF24-8916B13EFDE7

P921

Q34596441-AE5885C1-51AC-4E53-88C7-A8DD99944F5E

Q34596441-EFA0392B-668A-4C0E-9D3E-BD1C283B4309

P356

P1433

P1476

Treatment of unresectable chol ...... s: results from a pilot study.

@en

P2093

Al Benson

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Masterson

http://www.w3.org/2001/XMLSchema#string

Kent T Sato

http://www.w3.org/2001/XMLSchema#string

Mary F Mulcahy

http://www.w3.org/2001/XMLSchema#string

Reed A Omary

http://www.w3.org/2001/XMLSchema#string

Riad Salem

http://www.w3.org/2001/XMLSchema#string

Robert J Lewandowski

http://www.w3.org/2001/XMLSchema#string

Robert K Ryu

http://www.w3.org/2001/XMLSchema#string

Saad M Ibrahim

http://www.w3.org/2001/XMLSchema#string

Steven B Newman

http://www.w3.org/2001/XMLSchema#string

P304

2119-2128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.23818

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23225666

http://www.w3.org/2001/XMLSchema#string

P698

18759346

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma